Metastatic Left Colon and Rectal Cancer Treatment With Anti_EGFR Targeted Therapy
Condition(s):Metastatic Colorectal AdenocarcinomaLast Updated:October 16, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Metastatic Colorectal AdenocarcinomaLast Updated:October 16, 2023Completed
Condition(s):Unresectable Metastatic Colorectal CancerLast Updated:July 15, 2021Not yet recruiting
Condition(s):Unresectable Hepatocellular CarcinomaLast Updated:March 1, 2024Recruiting
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:August 10, 2022Completed
Condition(s):Non Small Cell Lung Cancer; Brain MetastasesLast Updated:December 10, 2019Unknown status
Condition(s):Recurrent, Refractory, or High Risk Leukemias; Matched Targeted TherapyLast Updated:November 1, 2023Active, not recruiting
Condition(s):Non Small Cell Lung CancerLast Updated:May 20, 2022Not yet recruiting
Condition(s):Lymphedema; Lymphedema Arm; Lymphedema of Upper Arm; Lymphedema of Upper Limb; Lymphedema of the Hands; Edema; Edema Arm; Breast Cancer Lymphedema; Breast Cancer Metastatic; Breast Cancer Stage; Breast CancerLast Updated:November 1, 2023Recruiting
Condition(s):Advanced Lung Cancer; SarcopeniaLast Updated:March 22, 2024Recruiting
Condition(s):MelanomaLast Updated:August 30, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.